Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.
Curr Opin Virol. 2013 Apr;3(2):205-9. doi: 10.1016/j.coviro.2013.01.001. Epub 2013 Feb 9.
Exotic and emerging viral pathogens associated with high morbidity and mortality in humans are being identified annually with recent examples including Lujo virus in southern Africa, Severe Fever with Thrombocytopenia Syndrome virus in China and a SARS-like coronavirus in the Middle East. The sporadic nature of these infections hampers our understanding of these diseases and limits the opportunities to design appropriate medical countermeasures against them. Because of this, animal models are utilized to gain insight into the pathogenesis of disease with the overall goal of identifying potential targets for intervention and evaluating specific therapeutics and vaccines. For these reasons it is imperative that animal models of disease recapitulate the human condition as closely as possible in order to provide the best predictive data with respect to the potential efficacy in humans. In this article we review the current status of disease models for highly pathogenic and emerging viral pathogens.
每年都会发现与人类高发病率和高死亡率相关的外来和新兴病毒病原体,最近的例子包括南部非洲的 Lujo 病毒、中国的发热伴血小板减少综合征病毒和中东的类似于 SARS 的冠状病毒。这些感染的偶发性阻碍了我们对这些疾病的理解,并限制了设计针对它们的适当医疗对策的机会。因此,利用动物模型来深入了解疾病的发病机制,其总体目标是确定潜在的干预靶点,并评估特定的治疗方法和疫苗。出于这些原因,疾病动物模型尽可能地重现人类疾病的状态是至关重要的,以便提供有关在人类中潜在疗效的最佳预测数据。在本文中,我们回顾了高致病性和新兴病毒病原体疾病模型的现状。